journal article·2025-12-24

DNA Nanoflowers Efficiently Encapsulate Photodynamic Agents and CRISPR/Cas9 for Synergistic Pancreatic Cancer Therapy

Nachuan Song, Gengqi Tian, Hongjin Li, Le Zhang, Yulong Wang, Weipeng Zhao, Chi Yao, Dayong Yang

Nano Letters· Volume 25· Issue 51
Publisher page

Abstract

Photodynamic therapy (PDT) holds significant promise for treating pancreatic cancer by utilizing photosensitizers to generate reactive oxygen species (ROS) that induce tumor cell death. However, the therapeutic efficacy of PDT is hindered by inadequate ROS accumulation. Herein, we develop a DNA nanoflower that enables the controlled codelivery of Cas9 ribonucleoprotein (RNP), hemin, and chlorin e6 for synergistic PDT. The Cas9 RNP selectively knocks out the antioxidant regulator nuclear factor E2-related factor 2 (Nrf2), thereby increasing cancer cells’ sensitivity to ROS. Simultaneously, the G-quadruplex/hemin complex catalyzes the conversion of endogenous H 2 O 2 into O 2, alleviating tumor hypoxia and supplying additional oxygen for PDT. This synergistic approach substantially amplifies ROS accumulation by attenuating ROS elimination and enhancing ROS generation, demonstrating high gene editing efficiency, significant Nrf2 down-regulation, elevated apoptosis, and remarkable antitumor efficacy in pancreatic cancer cells and a mouse model, underscoring the potential for precision medicine.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, State Key Laboratory of Molecular Engineering of Polymers

Fudan University

State Key Laboratory of Synthetic Biology, Frontiers Science Center for Synthetic Biology, Key Laboratory of Systems Bioengineering (MOE), School of Synthetic Biology and Biomanufacturing

Tianjin University

Department of Breast Oncology, Tianjin Medical University Cancer Institute & Hospital, National; Tianjin’s Clinical Research Center for Cancer; Key Laboratory of Breast Cancer Prevention and Therapy

Tianjin Medical University

Funding

Fudan University · National Natural Science Foundation of China · Tianjin Key Medical Discipline Construction Project

References (44)

Show source-provided references
1. 10.1002/anie.20191528110.1002/anie.201915281 ↗
2. 10.1002/anie.20191257410.1002/anie.201912574 ↗
3. 10.1039/D1CS00056J10.1039/D1CS00056J ↗
4. 10.1039/D0CS00173B10.1039/D0CS00173B ↗
5. 10.1039/C6CS00442C10.1039/C6CS00442C ↗
6. 10.1038/s41467-019-13115-310.1038/s41467-019-13115-3 ↗
7. 10.1038/s41467-023-36521-010.1038/s41467-023-36521-0 ↗
8. 10.1021/acs.chemrev.3c0006210.1021/acs.chemrev.3c00062 ↗
9. 10.1002/adma.20230515110.1002/adma.202305151 ↗
10. 10.1126/sciadv.abb400510.1126/sciadv.abb4005 ↗
11. 10.1002/adma.20210992010.1002/adma.202109920 ↗
12. 10.1002/adfm.20160067610.1002/adfm.201600676 ↗
13. 10.1002/anie.20240439510.1002/anie.202404395 ↗
14. 10.1002/adma.20140070310.1002/adma.201400703 ↗
15. 10.1002/adma.20210115810.1002/adma.202101158 ↗
16. 10.1002/adma.20210699610.1002/adma.202106996 ↗
17. 10.1002/advs.20240025110.1002/advs.202400251 ↗
18. 10.1146/annurev-pharmtox-011112-14032010.1146/annurev-pharmtox-011112-140320 ↗
19. 10.1002/anie.20211190010.1002/anie.202111900 ↗
20. 10.1126/science.aat501110.1126/science.aat5011 ↗
21. 10.1126/science.aay419810.1126/science.aay4198 ↗
22. 10.1126/sciadv.abj062410.1126/sciadv.abj0624 ↗
23. 10.1021/jacs.9b0904310.1021/jacs.9b09043 ↗
24. 10.1038/nnano.2012.21110.1038/nnano.2012.211 ↗
25. 10.1021/acs.chemrev.0c0029410.1021/acs.chemrev.0c00294 ↗
26. 10.1126/sciadv.adi360210.1126/sciadv.adi3602 ↗
27. 10.1002/adma.20230953410.1002/adma.202309534 ↗
28. 10.1021/acs.accounts.4c0030110.1021/acs.accounts.4c00301 ↗
29. 10.1021/nl400078g10.1021/nl400078g ↗
30. 10.1021/ja308985710.1021/ja3089857 ↗
31. 10.1021/jacs.0c0545310.1021/jacs.0c05453 ↗
32. 10.1002/anie.20110385310.1002/anie.201103853 ↗
33. 10.1007/s00604-019-3425-610.1007/s00604-019-3425-6 ↗
34. 10.1016/j.bios.2016.11.03210.1016/j.bios.2016.11.032 ↗
35. 10.1016/j.bios.2022.11413510.1016/j.bios.2022.114135 ↗
36. 10.1038/nbt.308110.1038/nbt.3081 ↗
37. 10.1002/adma.20190118710.1002/adma.201901187 ↗
38. 10.1126/sciadv.abe288810.1126/sciadv.abe2888 ↗
39. 10.1038/nature1018910.1038/nature10189 ↗
40. 10.1074/jbc.M111.28688010.1074/jbc.M111.286880 ↗
41. 10.1186/s12964-022-00906-310.1186/s12964-022-00906-3 ↗
42. 10.1021/jacs.3c0952910.1021/jacs.3c09529 ↗
43. 10.1021/jacs.2c0082310.1021/jacs.2c00823 ↗
44. 10.1002/EXP.2024010910.1002/EXP.20240109 ↗